RPS6KA1 and neoplasm: Although only a limited number of tumor samples were analyzed so far, the data obtained highlight an important role of p90RSK inhibition in blocking the progression of tumorigenesis, supporting researchers’ extensive efforts in the development of specific p90RSK inhibitors.